0001731122-20-000116.txt : 20200210 0001731122-20-000116.hdr.sgml : 20200210 20200210175920 ACCESSION NUMBER: 0001731122-20-000116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190827 FILED AS OF DATE: 20200210 DATE AS OF CHANGE: 20200210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Finestone Arnold CENTRAL INDEX KEY: 0001422489 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09927 FILM NUMBER: 20593225 MAIL ADDRESS: STREET 1: 1211 N. WESTSHORE BLVD. STREET 2: SUITE 512 CITY: TAMPA STATE: FL ZIP: 33607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Advanzeon Solutions, Inc. CENTRAL INDEX KEY: 0000022872 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 952594724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3405 W. DR. MARTIN LUTHER KING JR. BLVD. STREET 2: SUITE 101 CITY: TAMPA STATE: FL ZIP: 33607 BUSINESS PHONE: 813-288-4808 MAIL ADDRESS: STREET 1: 3405 W. DR. MARTIN LUTHER KING JR. BLVD. STREET 2: SUITE 101 CITY: TAMPA STATE: FL ZIP: 33607 FORMER COMPANY: FORMER CONFORMED NAME: COMPREHENSIVE CARE CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: NEURO PSYCHIATRIC & HEALTH SERVICES DATE OF NAME CHANGE: 19730501 FORMER COMPANY: FORMER CONFORMED NAME: NEURO PSYCHIATRIC & HEALTH SERVICES INC DATE OF NAME CHANGE: 19700402 4 1 ownership.xml X0306 4 2019-08-27 0 0000022872 Advanzeon Solutions, Inc. CHCR 0001422489 Finestone Arnold C/O 2901 W. BUSCH BLVD., SUITE 701 TAMPA FL 33618 1 1 0 0 CFO Common Stock 2019-08-27 4 J 0 5000000 .00 A 6577171 D The Board of Directors on August 26, 2019, changed the vesting date of the Issuer's Series D Preferred Stock from January 4, 2022, to August 27, 2019. Each share of the Series D Preferred Stock converts into 100,000 shares of Issuer's Common Stock. The Reporting Person owns 50 shares of the Series D Preferred Stock which are convertible into 5,000,000 shares of the Issuer's Common Stock. Represents 1,000,000 shares subject to options. 500,000 shares acquirable with a warrant, 77,171 shares obtainable from the conversation of 244 shares of the Issuer's Series C Preferred Stock and 50 shares of the Issuer's Series D Preferred Stock obtainable from the conversion of the Series D Preferred Stock. /s/ Arnold B. Finestone 2020-02-10